bf/NASDAQ:IMCR_icon.jpeg

COM:IMMUNOCORE

Immunocore Holdings plc

  • Stock

USD

Last Close

32.12

22/11 21:00

Market Cap

1.90B

Beta: -

Volume Today

190.00K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-71.63M
-
-103.93M
45.09%
-74.09M
28.71%
-131.52M
77.51%
-41.22M
68.66%
-55.29M
34.11%
depreciation and amortization
6.71M
-
9.21M
37.36%
8.98M
2.57%
7.01M
21.88%
6.13M
12.56%
4.09M
33.29%
deferred income tax
-16.55M
-
-22.26M
34.51%
-13.27M
40.39%
-9.40M
29.11%
-2.92M
68.94%
13.83M
573.37%
stock based compensation
666K
-
3.06M
358.86%
8.16M
167.08%
35.86M
339.37%
27.05M
24.56%
32.47M
20.02%
change in working capital
67.58M
-
-10.09M
114.93%
-28.80M
185.40%
-16.81M
41.65%
-12.88M
23.33%
5.78M
144.87%
accounts receivables
1.83M
-
-532K
129.10%
-5.15M
867.48%
-32.09M
523.47%
-17.87M
44.31%
inventory
-1.47M
-
-4.91M
233.31%
29.04M
691.11%
accounts payables
1.47M
-
4.91M
233.31%
2.63M
46.57%
other working capital
67.58M
-
-11.92M
117.64%
-28.27M
137.17%
-11.66M
58.76%
19.20M
264.72%
-8.01M
141.72%
other non cash items
-3.40M
-
22.64M
766.55%
38.45M
69.87%
-14.89M
138.72%
-7.42M
50.13%
2.06M
127.73%
net cash provided by operating activities
-16.63M
-
-101.38M
509.74%
-60.57M
40.25%
-129.75M
114.20%
-31.27M
75.90%
2.94M
109.40%
investments in property plant and equipment
-3.54M
-
-4.28M
20.89%
-3.07M
28.11%
-1.01M
67.21%
-2.20M
117.96%
-5.42M
146.93%
acquisitions net
purchases of investments
sales maturities of investments
27.45M
-
other investing activites
34.10M
-
139K
99.59%
3.54M
2,447.48%
513K
85.51%
2.43M
373.68%
net cash used for investing activites
58.01M
-
-4.14M
107.13%
467K
111.29%
-495K
206.00%
233K
147.07%
-5.42M
2,428.33%
debt repayment
-4.04M
-
-4.43M
9.66%
-3.16M
28.63%
-46.72M
1,378.85%
common stock issued
59.87M
-
83.22M
38.99%
226.53M
172.21%
116.81M
48.43%
common stock repurchased
dividends paid
other financing activites
101K
-
-711K
803.96%
37.15M
5,324.89%
52.88M
42.35%
68.13M
28.83%
34.35M
49.59%
net cash used provided by financing activities
101K
-
55.13M
54,481.19%
115.94M
110.32%
276.25M
138.27%
138.23M
49.96%
34.35M
75.15%
effect of forex changes on cash
13K
-
-33K
353.85%
-84K
154.55%
22K
126.19%
7.12M
32,272.73%
8.29M
16.44%
net change in cash
41.50M
-
-50.42M
221.49%
55.75M
210.57%
146.03M
161.94%
114.31M
21.72%
40.15M
64.87%
cash at beginning of period
82.88M
-
124.39M
50.07%
73.97M
40.53%
175.12M
136.75%
287.30M
64.06%
402.47M
40.09%
cash at end of period
124.39M
-
73.97M
40.53%
129.72M
75.37%
321.15M
147.58%
401.61M
25.05%
442.63M
10.21%
operating cash flow
-16.63M
-
-101.38M
509.74%
-60.57M
40.25%
-129.75M
114.20%
-31.27M
75.90%
2.94M
109.40%
capital expenditure
-3.54M
-
-4.28M
20.89%
-3.07M
28.11%
-1.01M
67.21%
-2.20M
117.96%
-5.42M
146.93%
free cash flow
-20.16M
-
-105.65M
423.99%
-63.65M
39.76%
-130.76M
105.44%
-33.47M
74.41%
-2.48M
92.57%

All numbers in USD (except ratios and percentages)